Aandelen in “Biotechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
Ocugen Inc |
20/05 | 1,920 USD
+0,52% |
+0,52% |
|
Ocuphire Pharma Inc |
20/05 | 1,790 USD
+6,23% |
+6,23% |
|
Omeros Corporation |
20/05 | 3,300 USD
-4,35% |
-4,35% |
Oncimmune Holdings plc |
17/05 | 2.450,000 GBX
0,00% |
0,00% |
|
Oncolytics Biotech, Inc. |
20/05 | 1,120 USD
+0,90% |
+0,90% |
|
Onconova Therapeutics Inc |
17/05 | 0,641 USD
-0,25% |
-0,25% |
|
Oncorus Inc |
29/12 | 0,126 USD
-3,08% |
-3,08% |
|
Oncternal Therapeutics Inc |
20/05 | 8,600 USD
-0,69% |
-0,69% |
|
Opgen Inc |
20/05 | 3,860 USD
-16,09% |
-16,09% |
|
Opiant Pharmaceuticals Inc |
1/03 | 20,650 USD
-0,58% |
-0,58% |
|
Opko Health Inc |
20/05 | 1,320 USD
0,00% |
0,00% |
|
Opthea Limited |
20/05 | 3,460 USD
+1,47% |
+1,47% |
|
OptiBiotix Health plc |
20/05 | 18,125 GBX
-99,00% |
-99,00% |
|
Oragenics Inc |
20/05 | 3,070 USD
+31,76% |
+31,76% |
|
Organovo Holdings Inc |
20/05 | 1,080 USD
+4,85% |
+4,85% |
|
Orgenesis Inc |
20/05 | 0,550 USD
-0,34% |
-0,34% |
OSE Immunotherapeutics |
20/05 | 7,190 EUR
-2,97% |
-2,97% |
|
Otonomy Inc |
11/04 | 0,009 USD
-92,64% |
-92,64% |
|
Outlook Therapeutics Inc |
20/05 | 7,950 USD
+2,19% |
+2,19% |
|
Oxford BioDynamics Plc |
20/05 | 7,600 GBX
-2,44% |
-2,44% |
|
Oxford BioMedica plc |
20/05 | 326,000 GBX
+0,77% |
+0,77% |
Oxurion |
20/05 | 0,000 EUR
-50,00% |
-50,00% |